Hello [[INITIATIVE.AUDIENCE MEMBER.FIRST NAME]], 

August being National Make-A-Will Month, got me thinking about what it means to care for the future.

When someone is diagnosed with liver cancer, so much attention understandably turns to what needs to happen right now. There are appointments to schedule, treatment decisions to make, questions to ask, and an unfamiliar medical landscape to navigate. But a serious diagnosis can also make us think about the people we love, the lives we are building, and what we hope to leave behind.

Planning for the future can be an act of love.

That is why I think of an up-to-date will as a love letter to the people and causes that have shaped our lives. It can give the people we love clarity about our wishes and provide peace of mind during an already difficult time.

Through Blue Faery's partnership with FreeWill, you can create or update your will online at no cost. You can also name beneficiaries for assets such as retirement accounts and life insurance policies.

August is also an opportunity to look toward the future by listening to those who have already traveled the path of liver cancer. On August 22, our next The Truth About Liver Cancer workshop will focus on Survivor Stories. Medical information can help us understand the disease, but survivors can tell us what it actually feels like to move through diagnosis, treatment, uncertainty, recovery, and life afterward.

Their experiences can offer perspective, connection, and hope to others facing liver cancer.

Our work to bring patients, caregivers, and experts together will continue this fall with our HCC Lunch & Learn in Chicago in October, presented by Blue Faery in partnership with University of Chicago Medicine. These programs create opportunities for people affected by hepatocellular carcinoma to learn, ask questions, and connect directly with medical professionals and others in the liver cancer community.

At Blue Faery, we cannot know exactly what the future will bring. What we can do is prepare for it, share what we know, learn from one another, and help make the path clearer for those who come after us.

The choices we make today can become a gift to someone tomorrow.

Fighting Liver Cancer Together,
Andrea Wilson Woods
Founder and President 

Support From People Who Understand

Facing hepatocellular carcinoma can feel overwhelming, but no one should have to navigate it alone. Blue Faery's free, HIPAA-compliant Liver Cancer Community provides a private space for patients and caregivers to connect, share experiences, ask questions, and find support from people who understand the liver cancer journey.

If you or someone you know is dealing with HCC, we invite you to join the community or share it with someone who may need support.

Join us on August 22 for our next The Truth About Liver Cancer workshop, featuring Survivor Stories. Hear directly from people who have faced liver cancer as they share their experiences with diagnosis, treatment, recovery, and life beyond primary liver cancer.

Their stories offer insight, encouragement, and connection for patients, caregivers, and anyone affected by HCC.

Join Blue Faery in partnership with University of Chicago Medicine in Chicago on October 24 for our upcoming HCC Lunch & Learn, an in-person educational event for patients, caregivers, and others affected by hepatocellular carcinoma.

Attendees will have the opportunity to hear from liver cancer experts, ask questions, gain practical information, and connect with others in the HCC community.

Space is limited, so we encourage you to register early and save your seat.

At ASCO 2026, Blue Faery volunteer Jeff Cape spoke with CURE about the importance of including patient voices in conversations about liver cancer.

In the interview, Jeff shares his perspective as an advocate and explains why lived experience is essential to improving awareness, support, and care for people affected by liver cancer.

Rezolute is seeking U.S.-based patients, caregivers, and patient advocacy leaders to join its new Lived Experience Advisory Council for people affected by tumor hyperinsulinism, including those impacted by hepatocellular carcinoma.

Council members will have the opportunity to share their experiences, perspectives, and unmet needs directly with Rezolute to help inform future programs and patient engagement efforts. Selected participants will be compensated for their time.

Participation is limited, and applications are currently being accepted.

*Indicates a paid listing. If your trial is no longer recruiting, please email Chasity right away.